naltrexone and Alloxan Diabetes

naltrexone has been researched along with Alloxan Diabetes in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (10.17)	18.7374
1990's	25 (42.37)	18.2507
2000's	17 (28.81)	29.6817
2010's	7 (11.86)	24.3611
2020's	4 (6.78)	2.80

Authors

Authors	Studies
Kareem, ZY; Kumari, R; McLaughlin, PJ	1
McLaughlin, PJ; Sassani, JW; Zagon, IS	1
McLaughlin, PJ; Purushothaman, I; Sassani, JW; Zagon, IS	1
Choubey, A; Ghosh, R; Mondal, P; Shitole, P	1
McLaughlin, PJ; Sassani, JW; Titunick, MB; Zagon, IS	1
Immonen, JA; McLaughlin, PJ; Sassani, JW; Zagon, IS	1
Immonen, JA; McLaughlin, PJ; Zagon, IS	2
Immonen, JA; Lewis, GS; McLaughlin, PJ; Zagon, IS	1
Fan, R; Feng, N; Guo, F; Jia, M; Li, J; Ma, X; Pei, J; Shang, Y; Wang, H; Wang, Y; Yin, Y; Zhang, S; Zhou, J	1
Ceballos-Reyes, G; Granados-Soto, V; Jiménez-Andrade, GY; Reyes-García, G; Sereno, G; Vidal-Cantú, GC	1
Amirshahrokhi, K; Dehpour, AR; Ghazi-Khansari, M; Hadjati, J; Sotoudeh, M	1
Klocek, MS; McLaughlin, PJ; Sassani, JW; Zagon, IS	3
Immonen, JA; McLaughlin, PJ; Pothering, CA; Zagon, IS	1
Fry, JL; Jenkins, JB; Lang, CM; McLaughlin, PJ; Ruth, TB; Sassani, JW; Wylie, JD; Zagon, IS	1
Kamei, J; Nozaki, C; Saitoh, A; Tamura, N	1
Kamei, J; Miyata, S; Saitoh, A; Takahashi, M	1
Aburada, M; Kase, Y; Murata, M; Omiya, Y; Suzuki, Y; Takeda, S; Yuzurihara, M	1
Kamei, J; Nozaki, C; Saitoh, A	1
Klocek, MS; Mauger, DT; McLaughlin, PJ; Sassani, JW; Zagon, IS	1
Kamei, J; Nozaki, C	1
McLaughlin, PJ; Myers, RL; Sassani, JW; Zagon, IS	1
Ambriz-Tututi, M; Araiza-Saldaña, CI; Arreola-Espino, R; Caram-Salas, NL; Granados-Soto, V; Mixcoatl-Zecuatl, T; Rocha-González, HI; Urquiza-Marín, H	1
Griffith, JW; Klocek, MS; Komáromy, AM; McLaughlin, PJ; Sassani, JW; Zagon, IS	1
Brown, DM; Handwerger, BS; Levine, AS; Morley, JE; Wilcox, G	1
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Ohsawa, M; Saitoh, A; Suzuki, T	1
Hitosugi, H; Kamei, J; Kasuya, Y	1
Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Suzuki, T	1
Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Ohsawa, M	2
Funada, M; Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Saitoh, A; Suzuki, T	1
Iwamoto, Y; Kamei, J; Kasuya, Y; Kawashima, N; Misawa, M; Nagase, H; Suzuki, T	1
Carr, KD	1
Hitosugi, H; Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H	2
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H	3
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Mizuno, D; Nagase, H; Okutomi, T; Soma, G; Suzuki, T	1
Gottreich, A; Homonnai, ZT; Oppenheim, D; Paz, G; Yavetz, H; Yogev, L	2
Hitosugi, H; Kamei, J; Kasuya, Y; Kawashima, N; Misawa, M; Nagase, H	1
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Suzuki, T	1
Kolta, MG; Ngong, JM; Pierzchala, K; Rutledge, LP; Van Loon, GR	1
Hitosugi, H; Kamei, J; Kashiwazaki, T; Nagase, H	1
Fujimoto, JM; Gorny, JM; Rady, JJ	1
Hitosugi, H; Kamei, J; Kashiwazaki, T; Nagase, H; Taki, K	1
Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J; Privat, AM; Zajac, JM	1
Kamei, J; Nagase, H; Ohsawa, M; Zushida, K	1
Boucher, M; Coudoré-Civiale, MA; Eschalier, A; Fournié-Zaluski, MC; Méen, M; Roques, BP	1
Kamei, J; Kasuya, Y; Kawashima, N	1
Kamei, J; Kasuya, Y; Kawashima, N; Ohhashi, Y	1
Emmanouil, DE; Ishii, MM; Quock, RM	1
Billington, CJ; Brown, DM; Gosnell, BA; Grace, M; Krahn, DD; Levine, AS; Morley, JE	1
Garris, DR; Michel, ME	1
Brezner, E; Gottreich, A; Homonnai, ZT; Paz, GF; Yogev, L	1
Gottriech, A; Homonnai, ZT; Paz, GF; Timan, B; Yogev, L	1

Other Studies

59 other study(ies) available for naltrexone and Alloxan Diabetes

Article	Year
Acute Low Dose Naltrexone Increases β-Endorphin and Promotes Neuronal Recovery Following Hypoxia-Ischemic Stroke in Type-2 Diabetic Mice. Neurochemical research, 2023, Volume: 48, Issue:9 Topics: Animals; beta-Endorphin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Ischemic Stroke; Male; Mice; Naltrexone; Neurons	2023
Safety study of topical naltrexone therapy for diabetic skin wounds is confirmed in Göttingen mini-pigs. Drug development research, 2023, Volume: 84, Issue:6 Topics: Animals; Diabetes Mellitus, Experimental; Female; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Swine; Swine, Miniature	2023
Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications. Experimental biology and medicine (Maywood, N.J.), 2021, Volume: 246, Issue:5 Topics: Animals; Blood Glucose; Body Weight; Cornea; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Enkephalin, Methionine; Eye; Male; Naltrexone; Rats, Sprague-Dawley; Receptors, Opioid; Severity of Illness Index; Time Factors	2021
Influence of low dose naltrexone on Raman assisted bone quality, skeletal advanced glycation end-products and nano-mechanical properties in type 2 diabetic mice bone. Materials science & engineering. C, Materials for biological applications, 2021, Volume: 123 Topics: Animals; Bone and Bones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Mice; Naltrexone	2021
Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes. BMC ophthalmology, 2019, Jan-28, Volume: 19, Issue:1 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Male; Naltrexone; Narcotic Antagonists; Rabbits; Rats; Rats, Sprague-Dawley; Tears	2019
Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone. Clinical & experimental ophthalmology, 2014, Volume: 42, Issue:2 Topics: Administration, Topical; Animals; Blood Glucose; Corneal Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dry Eye Syndromes; Epithelium, Corneal; Fluorophotometry; Intraocular Pressure; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Ophthalmic Solutions; Re-Epithelialization; Tears; Wound Healing	2014
Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis. Experimental biology and medicine (Maywood, N.J.), 2013, Volume: 238, Issue:7 Topics: Actins; Administration, Topical; Animals; Blood Glucose; Body Weight; Cell Count; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fibroblast Growth Factor 2; Hyperglycemia; Inflammation; Male; Mast Cells; Naltrexone; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Skin; Streptozocin; Vascular Endothelial Growth Factor A; Wound Healing	2013
Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats. Experimental biology and medicine (Maywood, N.J.), 2013, Volume: 238, Issue:10 Topics: Administration, Topical; Animals; Diabetes Mellitus, Experimental; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Treatment Outcome; Wound Healing; Wounds and Injuries	2013
Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing. Experimental biology and medicine (Maywood, N.J.), 2014, Volume: 239, Issue:10 Topics: Animals; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Fibroblasts; Mice; Naltrexone; Narcotic Antagonists; Rats, Sprague-Dawley; Wound Healing	2014
Activation of κ-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice. Journal of cellular biochemistry, 2015, Volume: 116, Issue:2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adiponectin; AMP-Activated Protein Kinases; Analgesics, Non-Narcotic; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Gene Expression; Glucose Transporter Type 4; Homeostasis; Hyperglycemia; Insulin; Male; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Phosphorylation; Protein Transport; Receptors, Adiponectin; Receptors, Opioid, kappa; Reverse Transcriptase Polymerase Chain Reaction	2015
Pyritinol reduces nociception and oxidative stress in diabetic rats. European journal of pharmacology, 2008, Aug-20, Volume: 590, Issue:1-3 Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Female; Indomethacin; Naltrexone; Oxadiazoles; Oxidative Stress; Pyrithioxin; Quinoxalines; Rats; Rats, Wistar; Streptozocin	2008
Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Toxicology and applied pharmacology, 2008, Oct-01, Volume: 232, Issue:1 Topics: Animals; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Administration Schedule; Hypoglycemic Agents; Immunosuppressive Agents; Injections, Intraperitoneal; Insulin; Methadone; Mice; Naltrexone; Narcotic Antagonists; Pancreas; Receptors, Opioid, mu; Streptozocin; Time Factors	2008
Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats. Experimental eye research, 2009, Volume: 89, Issue:5 Topics: Administration, Topical; Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; DNA Replication; Drug Therapy, Combination; Epithelium, Corneal; Hypoglycemic Agents; Insulin; Intraocular Pressure; Male; Naltrexone; Narcotic Antagonists; Necrosis; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Time Factors; Wound Healing	2009
Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus. Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:11 Topics: Administration, Topical; Animals; Cornea; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Sensation; Tears	2009
Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats. Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:10 Topics: Administration, Topical; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; DNA; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Skin; Wound Healing	2011
Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. Diabetes, 2002, Volume: 51, Issue:10 Topics: Animals; Corneal Ulcer; Diabetes Mellitus, Experimental; DNA; Enkephalin, Methionine; Epithelial Cells; Epithelium, Corneal; Male; Microscopy, Electron; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Wound Healing	2002
Antinociceptive effect of oxycodone in diabetic mice. European journal of pharmacology, 2005, Nov-07, Volume: 524, Issue:1-3 Topics: Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Morphine; Naltrexone; Narcotic Antagonists; Oxycodone; Pain; Pain Measurement; Time Factors	2005
Involvement of delta1-opioid receptors in the spatial learning impairment in streptozotocin-induced diabetic mice. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2005, Volume: 25, Issue:5 Topics: Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Enkephalins; Escape Reaction; Mice; Naltrexone; Reaction Time; Receptors, Opioid, delta; Space Perception	2005
Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice. Journal of pharmacological sciences, 2005, Volume: 99, Issue:4 Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Glycyrrhiza; Male; Medicine, Kampo; Methysergide; Mice; Naltrexone; Narcotic Antagonists; Oxidopamine; Paeonia; Pain Measurement; Pain Threshold; Piperazines; Serotonin Antagonists; Sympatholytics; Tropanes; Yohimbine	2005
Characterization of the antinociceptive effects of oxycodone in diabetic mice. European journal of pharmacology, 2006, Mar-27, Volume: 535, Issue:1-3 Topics: Analgesics, Opioid; Animals; Area Under Curve; Diabetes Mellitus, Experimental; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Oxycodone; Pain; Pain Measurement; Streptozocin	2006
Corneal safety of topically applied naltrexone. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:5 Topics: Administration, Topical; Animals; Apoptosis; Cell Count; Cornea; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelium, Corneal; Male; Naltrexone; Narcotic Antagonists; Necrosis; Rats; Rats, Sprague-Dawley	2006
Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice. European journal of pharmacology, 2007, Apr-10, Volume: 560, Issue:2-3 Topics: Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Oxycodone; Receptors, Opioid, mu; Streptozocin	2007
Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium. Brain research bulletin, 2007, Apr-02, Volume: 72, Issue:1 Topics: Animals; Basement Membrane; Diabetes Mellitus, Experimental; Epithelium, Corneal; Hemidesmosomes; Male; Microscopy, Electron, Transmission; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Wound Healing	2007
Topically applied naltrexone restores corneal reepithelialization in diabetic rats. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2007, Volume: 23, Issue:2 Topics: Administration, Topical; Animals; Apoptosis; Cell Count; Cornea; Corneal Ulcer; Diabetes Mellitus, Experimental; DNA; Dose-Response Relationship, Drug; Epithelium, Corneal; Male; Naltrexone; Narcotic Antagonists; Necrosis; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Wound Healing	2007
Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats. European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3 Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Female; Formaldehyde; Guanidines; Indoles; Melatonin; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Postural Balance; Rats; Rats, Wistar; Receptor, Melatonin, MT2	2007
Prevention of exuberant granulation tissue and neovascularization in the rat cornea by naltrexone. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:4 Topics: Administration, Topical; Animals; Blood Glucose; Corneal Neovascularization; Debridement; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epithelium, Corneal; Fluorophotometry; Granulation Tissue; Male; Naltrexone; Narcotic Antagonists; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Wound Healing	2008
Tail pinch behavior and analgesia in diabetic mice. Physiology & behavior, 1982, Volume: 28, Issue:1 Topics: Animals; Consummatory Behavior; Diabetes Mellitus, Experimental; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Mice; Mice, Inbred C57BL; Motor Activity; Naltrexone; Nociceptors; Sensory Thresholds; Stress, Physiological; Tail	1982
Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:2 Topics: Animals; Diabetes Mellitus, Experimental; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Mice; Mice, Inbred ICR; Morphine; Morphine Dependence; Motor Activity; Naloxone; Naltrexone; Receptors, Opioid, mu; Streptozocin	1995
Formalin-induced nociceptive responses in diabetic mice. Neuroscience letters, 1993, Jan-12, Volume: 149, Issue:2 Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Formaldehyde; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptors; Receptors, Opioid, delta; Substance P	1993
Antinociceptive effect of dihydroetorphine in diabetic mice. European journal of pharmacology, 1995, Feb-24, Volume: 275, Issue:1 Topics: Analgesia; Analgesics, Opioid; Animals; Binding, Competitive; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Etorphine; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu	1995
Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1995, Volume: 15, Issue:2 Topics: Animals; Depression, Chemical; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Gastrointestinal Transit; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Naltrexone	1995
Effects of diabetes on spontaneous locomotor activity in mice. Neuroscience letters, 1994, Aug-29, Volume: 178, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzylidene Compounds; Brain; Corpus Striatum; Diabetes Mellitus, Experimental; Dopamine; Haloperidol; Homovanillic Acid; Male; Mice; Mice, Inbred ICR; Motor Activity; Naltrexone; Narcotic Antagonists; Prosencephalon; Receptors, Dopamine D1; Receptors, Opioid, delta; Reference Values	1994
Effects of diabetes on the morphine-induced Straub tail reaction in mice. Neuroscience letters, 1994, Aug-29, Volume: 178, Issue:1 Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reference Values; Tail	1994
The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice. Psychopharmacology, 1993, Volume: 113, Issue:2 Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Monocytes; Morphine; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu; Spleen	1993
Streptozotocin-induced diabetes produces a naltrexone-reversible lowering of self-stimulation threshold. Brain research, 1994, Nov-21, Volume: 664, Issue:1-2 Topics: Animals; Diabetes Mellitus, Experimental; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Reward; Self Stimulation; Streptozocin	1994
Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors. Neuroscience letters, 1994, Jan-03, Volume: 165, Issue:1-2 Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Receptors, Opioid, mu; Spinal Cord	1994
Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors. Life sciences, 1994, Volume: 55, Issue:6 Topics: Analgesia; Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Mice, Inbred ICR; Naltrexone; Oligopeptides; Receptors, Opioid, delta; Receptors, Opioid, mu; Streptozocin	1994
Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice. Research communications in chemical pathology and pharmacology, 1994, Volume: 84, Issue:1 Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Drug Synergism; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptors; Pentazocine; Receptors, Opioid, kappa; Receptors, Opioid, mu	1994
Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice. European journal of pharmacology, 1994, Jan-04, Volume: 251, Issue:1 Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enterobacter; Injections, Subcutaneous; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement	1994
Serum prolactin response to ether stress in diabetic rats: opiate system contribution. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1994, Volume: 205, Issue:3 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Ether; Male; Morphine; Naltrexone; Narcotic Antagonists; Prolactin; Rats; Rats, Wistar; Receptors, Opioid; Stress, Physiological	1994
Differential mediation of cold water swim stress-induced antinociception by delta-opioid receptor subtypes in diabetic mice. Life sciences, 1994, Volume: 54, Issue:23 Topics: Analgesia; Animals; Benzylidene Compounds; Cold Temperature; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; Naltrexone; Receptors, Opioid, delta; Streptozocin; Stress, Physiological; Swimming	1994
Antinociceptive effect of L-arginine in diabetic mice. European journal of pharmacology, 1994, Mar-11, Volume: 254, Issue:1-2 Topics: Analgesics; Animals; Arginine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endorphins; Injections, Intraventricular; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nitroarginine; Pain Measurement; Reaction Time	1994
Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin. Life sciences, 1994, Volume: 54, Issue:4 Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Luteinizing Hormone; Male; Naltrexone; Prolactin; Rats; Rats, Wistar; Receptors, Opioid; Streptozocin	1994
Effect of diabetes on the antinociceptive effect of beta-endorphin. Brain research, 1993, Aug-13, Volume: 619, Issue:1-2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; beta-Endorphin; Cerebral Ventricles; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain; Pyrrolidines; Reference Values	1993
Antitussive effects of mu- and kappa-agonists in diabetic rats. Neuroscience letters, 1993, May-14, Volume: 154, Issue:1-2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Antitussive Agents; Diabetes Mellitus, Experimental; Male; Morphine; Naltrexone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu	1993
Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides, 1996, Volume: 30, Issue:4 Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Chronic Disease; Diabetes Mellitus, Experimental; Endorphins; Enkephalin, Methionine; Half-Life; Hypoglycemic Agents; Insulin; Male; Naltrexone; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley	1996
The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice. European journal of pharmacology, 1997, May-12, Volume: 326, Issue:1 Topics: Analgesics; Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Formaldehyde; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Spinal Cord	1997
Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice. Japanese journal of pharmacology, 1998, Volume: 78, Issue:4 Topics: Analgesics, Opioid; Animals; Anti-Bacterial Agents; Benzylidene Compounds; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Heroin; Injections, Intraventricular; Male; Mice; Morphine; Morphine Derivatives; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Receptors, Opioid, delta; Receptors, Opioid, mu; Streptozocin; Time Factors	1998
Algogenic mediator-induced nociceptive response in diabetic mice. European journal of pharmacology, 1999, Mar-26, Volume: 369, Issue:3 Topics: Animals; Benzylidene Compounds; Bradykinin; Diabetes Mellitus, Experimental; Dinoprost; Dose-Response Relationship, Drug; Formaldehyde; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain; Receptors, Opioid, delta; Somatostatin	1999
Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats. British journal of pharmacology, 1999, Volume: 127, Issue:6 Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperalgesia; Injections, Spinal; Male; Morphine; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Oligopeptides; Pain; Rats; Rats, Sprague-Dawley; Somatostatin; Time Factors; Vocalization, Animal	1999
The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. European journal of pharmacology, 2000, Mar-10, Volume: 391, Issue:1-2 Topics: Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Oligopeptides; Pain Measurement; Reaction Time; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu	2000
Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats. British journal of pharmacology, 2001, Volume: 133, Issue:1 Topics: Aminopeptidases; Animals; Diabetes Mellitus, Experimental; Disulfides; Drug Synergism; Indoles; Male; Meglumine; Naloxone; Naltrexone; Neprilysin; Pain; Pain Measurement; Phenylalanine; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Time Factors; Vocalization, Animal; Weight Loss	2001
Naloxone-induced analgesia in diabetic mice. European journal of pharmacology, 1992, Jan-21, Volume: 210, Issue:3 Topics: Analgesia; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid	1992
Effects of diabetes on stress-induced analgesia in mice. Brain research, 1992, May-15, Volume: 580, Issue:1-2 Topics: Animals; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Physical Exertion; Receptors, Opioid, mu; Sensory Thresholds; Stress, Physiological	1992
Central pharmacological activity of a quaternary ammonium compound in streptozotocin diabetic mice. Life sciences, 1988, Volume: 43, Issue:17 Topics: Animals; Blood-Brain Barrier; Cell Membrane Permeability; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Insulin; Mice; Morphine; Naltrexone; Narcotic Antagonists; Pharmaceutical Vehicles; Quaternary Ammonium Compounds; Streptozocin	1988
Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats. Pharmacology, biochemistry, and behavior, 1988, Volume: 29, Issue:3 Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Eating; Energy Metabolism; Male; Morphine; Naltrexone; Rats; Rats, Inbred Strains	1988
Regional brain glucose uptake in genetically diabetic C57BL/KsJ mice: modulation by the opiate antagonist, nalmefene. Brain research, 1988, Apr-05, Volume: 445, Issue:2 Topics: Animals; Brain; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Experimental; Female; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Naltrexone; Narcotic Antagonists; Organ Specificity; Reference Values	1988
Opiate system involvement in the control of LH secretion in diabetic and normoglycemic male rats. Life sciences, 1987, Aug-03, Volume: 41, Issue:5 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Kinetics; Luteinizing Hormone; Male; Naltrexone; Prolactin; Rats; Rats, Inbred Strains	1987
Changes in LH and prolactin levels in diabetic male rats and the role of the opiate system in the control of their secretion. Life sciences, 1985, Sep-16, Volume: 37, Issue:11 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Infertility, Male; Luteinizing Hormone; Male; Naltrexone; Prolactin; Rats; Secretory Rate; Time Factors	1985